Source: Sekisui XenoTech Youtube Channel

Sekisui XenoTech posted a video "In Vitro Evaluation of Immunomodulating Drugs as Perpetrators of Drug Interactions" on YOUTUBE

See Video »

Sekisui XenoTech's Competitors | Sekisui XenoTech's News | Sekisui XenoTech's Financials

Followers on Owler

Est. Annual Revenue

$25-100M

Est. Employees

100-250

President & CEO

Darren Warren

CEO Approval Rating

86/100

Sekisui XenoTech is a Kansas-based contract research organization that offers services including in vitro pharmacology and toxicokinetic analysis for the biotechnology sector.